09:13 AM EST, 11/04/2025 (MT Newswires) -- Ideaya Biosciences ( IDYA ) reported Q3 net income Tuesday of $1.33 per diluted share.

Revenue for the quarter ended Sept. 30 was $207.8 million. Analysts surveyed by FactSet expected $6.3 million.

The biotech company didn't provide year-ago figures.

As of Sept. 30, the company said it had cash, cash equivalents and marketable securities of about $1.14 billion, which it expects to fund operations into 2030.

Shares of Ideaya Biosciences ( IDYA ) were up 1.5% in recent premarket activity Tuesday.